UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Government urged to depart from 'disease-oriented' psychiatric R&D investment
by Nam Doo-hyun
2017-03-21 16:19
Korean drug makers struggle in Central Asia
by Nam Doo-hyun
2017-03-17 09:13
China's economic retaliation spreads to healthcare sector
by Nam Doo-hyun
2017-03-16 09:39
Why some pharms' operating profits plunged last year?
by Nam Doo-hyun
2017-03-08 18:18
Expert laments three 'nos' in drug industry
by Nam Doo-hyun
2017-03-03 11:32
라인
InBody's export increase raises hopes for 2017 growth
by Nam Doo-hyun
2017-03-02 16:20
Can Hongneung area be reborn as 'bio cluster'?
by Nam Doo-hyun
2017-02-27 17:08
'Troublemaker Doctor' out of the Hospital and into the Hot Bio-Industry
by Nam Doo-hyun
2017-02-16 08:30
VR Use on the Rise in Medical Fields
by Nam Doo-hyun
2017-02-15 18:07
It’s a War, Not a Battle
by Nam Doo-hyun
2017-02-15 08:00
라인
Samsung BioLogics Refutes KOSPI Listing Suspicions
by Nam Doo-hyun
2017-02-11 08:49
Korea’s Gene Analysis Technology Goes Global with Spearhead Macrogen
by Nam Doo-hyun
2017-02-07 12:27
“Korean Medical Devices, Good Brand Images but More Expensive than Chinese Ones”
by Nam Doo-hyun
2017-01-31 14:31
Research Centered Hospitals of Korea: “Numbers Do Not Matter”
by Nam Doo-hyun
2017-01-31 12:26
Lackluster Genome Analysis Industry in Korea; Calls for Localization
by Nam Doo-hyun
2017-01-31 08:22
라인
Japan Trying to Benchmark Korean Bio Industry Complex
by Nam Doo-hyun
2017-01-26 08:37
“Building a Bio Complex Where More than 50,000 Medical Personnel Can Work”
by Nam Doo-hyun
2017-01-24 10:23
7 Things Hospitals for Overseas Expansion Should Keep in Mind
by Nam Doo-hyun
2017-01-20 10:56
Bio and Pharmaceutical Stocks Smiling in the First Week of 2017
by Nam Doo-hyun
2017-01-17 09:09
Last Year, Export and Import of Pharmaceutical Products Exceeded $2billion and $5billion for the First Time
by Nam Doo-hyun
2017-01-06 15:15
-
이전
11
12
13
14
15
16
17
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top